ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 845 filers reported holding ISHARES TR in Q1 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,727 | -1.7% | 218 | 0.0% | 0.02% | +25.0% |
| Q1 2023 | $28,207 | -1.6% | 218 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $28,672 | -4.4% | 218 | -14.2% | 0.01% | 0.0% |
| Q3 2022 | $30,000 | 0.0% | 254 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $30,000 | -54.5% | 254 | -50.0% | 0.01% | 0.0% |
| Q1 2022 | $66,000 | +69.2% | 508 | +100.0% | 0.01% | -17.6% |
| Q4 2021 | $39,000 | -4.9% | 254 | 0.0% | 0.02% | -15.0% |
| Q3 2021 | $41,000 | -2.4% | 254 | 0.0% | 0.02% | -9.1% |
| Q2 2021 | $42,000 | +133.3% | 254 | +108.2% | 0.02% | +100.0% |
| Q1 2021 | $18,000 | +38.5% | 122 | +47.0% | 0.01% | +22.2% |
| Q4 2020 | $13,000 | +18.2% | 83 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $11,000 | -35.3% | 83 | -34.6% | 0.01% | -38.5% |
| Q2 2020 | $17,000 | -15.0% | 127 | -31.0% | 0.01% | -31.6% |
| Q1 2020 | $20,000 | -9.1% | 184 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $22,000 | – | 184 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |